---
title: "ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279072314.md"
description: "ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso"
datetime: "2026-03-13T16:30:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279072314.md)
  - [en](https://longbridge.com/en/news/279072314.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279072314.md)
---

# ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso

ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso

### Related Stocks

- [OPHLY.US](https://longbridge.com/en/quote/OPHLY.US.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [4528.JP](https://longbridge.com/en/quote/4528.JP.md)

## Related News & Research

- [AstraZeneca Gets U.S. Approval for Hypertension Drug](https://longbridge.com/en/news/286724028.md)
- [Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer | AZN Stock News](https://longbridge.com/en/news/286621973.md)
- [<![CDATA[FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry]]>](https://longbridge.com/en/news/286792193.md)
- [AstraZeneca Scores Key FDA Wins Across Cardiovascular And Oncology Portfolios](https://longbridge.com/en/news/286801629.md)
- [<![CDATA[FDA Approves Fasenra for Hypereosinophilic Syndrome]]>](https://longbridge.com/en/news/286576027.md)